4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Spruce Biosciences, Inc. (SPRB) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 14 employees. Its market capitalization is roughly $142 million. In the fiscal year ended 2025-12-31, SPRB reported $0M in revenue and ($39M) in net income.
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $5M | $10M | $0M | — |
| Operating Income (EBIT) | ($36M) | ($56M) | ($52M) | ($47M) | — |
| Net Income | ($39M) | ($53M) | ($48M) | ($46M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($12M) | ($11M) | ($8M) | ($3M) | ($14M) | — |
| Net Income | ($12M) | ($15M) | ($8M) | ($2M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $53M | $45M | $104M | $86M | — |
| Total Liabilities | $10M | $16M | $27M | $17M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SPRB viewer.
About TickerBase · Data methodology & sources